Get the Stockscreener App
0.4071
1.52%
+0.0061
Pre-market:
.40
-0.0071
-1.74%
Singular Genomics Systems Inc stock is currently priced at $0.4071, with a 24-hour trading volume of 95,161.
It has seen a +1.52% increased in the last 24 hours and a -19.70% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.404 pivot point. If it approaches the $0.413 resistance level, significant changes may occur.
Previous Close:
$0.401
Open:
$0.416
24h Volume:
95,161
Market Cap:
$30.15M
Revenue:
$2.91M
Net Income/Loss:
$-94.82M
P/E Ratio:
-0.3132
EPS:
-1.3
Net Cash Flow:
$-74.62M
1W Performance:
-0.07%
1M Performance:
-19.70%
6M Performance:
+23.25%
1Y Performance:
-58.22%
1D Range:
$0.395
$0.433
52W Range:
$0.3101
$1.21
Singular Genomics Systems Inc Stock (OMIC) Company Profile
Name
Singular Genomics Systems Inc
Sector
Industry
Phone
858-333-7830
Address
10931 North Torrey Pines Road, Suite 100, LA Jolla
Singular Genomics Systems Inc Stock (OMIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-22 | Downgrade | UBS | Buy → Neutral |
| Aug-10-22 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
Singular Genomics Systems Inc Stock (OMIC) Latest News
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
GlobeNewswire Inc.
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
GlobeNewswire Inc.
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
GlobeNewswire Inc.
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
GlobeNewswire Inc.
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
GlobeNewswire Inc.
Singular Genomics Systems Inc Stock (OMIC) Financials Data
Singular Genomics Systems Inc (OMIC) Revenue 2024
OMIC reported a revenue (TTM) of $2.91 million for the quarter ending December 31, 2023.
Singular Genomics Systems Inc (OMIC) Net Income 2024
OMIC net income (TTM) was -$94.82 million for the quarter ending December 31, 2023, a -4.34% decrease year-over-year.
Singular Genomics Systems Inc (OMIC) Cash Flow 2024
OMIC recorded a free cash flow (TTM) of -$74.62 million for the quarter ending December 31, 2023, a +19.87% increase year-over-year.
Singular Genomics Systems Inc (OMIC) Earnings per Share 2024
OMIC earnings per share (TTM) was -$1.30 for the quarter ending December 31, 2023, a -2.36% decline year-over-year.
About Singular Genomics Systems Inc
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
0.69%
0.07%
Cap:
|
Volume (24h):